About PPA   |   Contact Us   |   Sign In   |   Join Now
Federal Issues

Pharmacy Issues at the Federal Level 

While we can't afford to be in Washington on a regular basis, PPA does work closely with a number of National Associations on their advocacy efforts on the federal level. PPA receives regular communications from various national groups, is in regular contact with staff of several associations, attends national pharmacy conferences, and assists in lobbying the Pennsylvania congressional delegation.


Provider Status

Pharmacists Provide Care is APhA's national advocacy campaign to achieve "provider status," which will allow pharmacists to be recognized as health care providers under the law. Being recognized as health care providers is critical to creating and expanded job opportunities.


Click here to support our profession and join APhA's Pharmacists Provide Care campaign today!


Additionally, NACDS is promoting "provider status" for pharmacists at the national level by advocating for the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592 / S.109). These bills would allow Medicare Part B to utilize pharmacists to their full capability by providing services to underserved beneficiaries. Pennsylvania's over 16,000 pharmacists can play a vital role in enhancing access to patient care in the 59 counties currently designated as "medically underserved.


Urge your federal legislators to support the Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592 and S.109) by clicking here!


"Pharmacy: Health policy’s shot-in-the-arm?" by Steven C. Anderson of The Hill (March 14, 2017)



DIR Fees

Direct and indirect remuneration (DIR) fees levied on pharmacy providers result in enormous clawbacks taken from community pharmacies weeks or months after prescriptions are filled. Such retroactive fees on pharmacies can artificially inflate patient costs and force Medicare beneficiaries into the "coverage gap" sooner. NCPA is actively working to combat this issue and is supporting the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (H.R.1038 / S.413), which would ban retroactive payment reductions and increase transparency.



Drug Importation

PPA is partnering with national organizations to ensure patients receive medications from licensed United States pharmacies and to decrease the supply of counterfeit medications. Click here to learn more about this topic from the Partnership for Safe Medicines. 


Click here to contact your federal legislators and let them know the dangers of allowing unlicensed foreign fake pharmacies to dispense in the United States. Additionally, you can learn more about Senator Casey's stance on this issue by clicking here to read his response or by visiting his website at www.casey.senate.gov.



Highlights of PPA's Efforts

Proposal Would Help Medically Underserved Areas - Ed Bechtel (December 20, 2015)


Recognize pharmacists as providers under Medicare, help system for seniors - Patricia Epple (August 25, 2015)


On March 28, 2017, the Pennsylvania Pharmacists Association (PPA), along with with 117 other health care groups, signed on to letters supporting the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (H.R.1038 / S.413) that were then sent to members of the United States Congress. Click here to view the letter sent to members of the United States Senate and click here to view the letter sent to members of the United States House of Representatives.

Association Management Software Powered by YourMembership  ::  Legal